Safety and early data from a phase II trial of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (Hl) and follicular lymphoma (FL) Meeting Abstract


Authors: Sermer, D.; Vardhana, S.; Batlevi, C.; Hamilton, A.; Moskowitz, A.; Caron, P.; Moskowitz, C.; Matasar, M.; Biggar, E.; Leung, E.; Yahalom, J.; Rademaker, J.; Dogan, A.; Seshan, V.; Younes, A.
Abstract Title: Safety and early data from a phase II trial of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (Hl) and follicular lymphoma (FL)
Meeting Title: 15th International Conference on Malignant Lymphoma
Journal Title: Hematological Oncology
Volume: 37
Issue: Suppl. 2
Meeting Dates: 2019 Jun 18-22
Meeting Location: Lugano, Switzerland
ISSN: 0278-0232
Publisher: Wiley Blackwell  
Date Published: 2019-06-01
Start Page: 331
End Page: 332
Language: English
ACCESSION: 137029154
DOI: 10.1002/hon.143_2630
PROVIDER: EBSCOhost
PROVIDER: cin20
PUBMED: 31187525
DOI/URL:
Notes: Meeting abstract: 279 -- Accession Number: 137029154 -- Entry Date: In Process -- Revision Date: 20190620 -- Publication Type: Article -- Supplement Title: Jun2019 Supplement S2 -- Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 8307268. -- Source: cin20
Altmetric Score
MSK Authors
  1. Venkatraman Ennapadam Seshan
    296 Seshan
  2. Joachim Yahalom
    420 Yahalom
  3. Craig Moskowitz
    379 Moskowitz
  4. Alison Moskowitz
    162 Moskowitz
  5. Matthew J Matasar
    134 Matasar
  6. Philip C Caron
    38 Caron
  7. Connie Wing-Ching Lee
    58 Lee
  8. Anas Younes
    223 Younes
  9. Ahmet Dogan
    185 Dogan
  10. David Sermer
    4 Sermer
  11. Erin Biggar
    1 Biggar
  12. Echo Leung
    1 Leung